|
Federal
Register Notices > Notices of Registration -
2007 >
Lipomed, Inc.
FR Doc E7-18704 [Federal Register: September 21, 2007 (Volume
72, Number 183)] [Notices] [Page 54069-54070] From the Federal
Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21se07-123]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated June 26, 2007 and published in the Federal
Register on July 3, 2007, (72 FR 36482-36483), Lipomed, Inc.,
One Broadway, Cambridge, Massachusetts 02142, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of the basic classes of controlled
substances listed in schedule I and II:
[[Page 54070]]
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
Methaqualone (2565)
|
I
|
|
Gamma-Hydroxybutyric Acid (2010)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348)
|
I
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
|
3,4,5-Trimethoxyamphetamine (7390)
|
I
|
|
4-Bromo-2-5-dimethoxyamphetamine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphyenethylamine (7392)
|
I
|
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
2,5-Dimethoxy-4-ethylamphetamine (7399)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Dimethyltryptamine (7435)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
Acetyldihydrocodeine (9051)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Heroin (9200)
|
I
|
|
Normorphine (9313)
|
I
|
|
Pholcodine (9314)
|
I
|
|
Tilidine (9750)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage forms) (9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Fentanyl (9801)
|
II
|
|
Sufentanil (9740)
|
II
|
The company plans to import analytical reference standards
for distribution to its customers for research and analytical
purposes.
No comments or objections have been received. DEA has
considered the factors in 21
U.S.C. 823(a) and Sec. 952(a) and
determined that the registration of Lipomed, Inc. to import the
basic classes of controlled substances is consistent with the
public interest and with United States obligations under
international treaties, conventions, or protocols in effect on
May 1, 1971, at this time. DEA has investigated Lipomed, Inc. to
ensure that the company's registration is consistent with the
public interest. The investigation has included inspection and
testing of the company's physical security systems, verification
of the company's compliance with state and local laws, and a
review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 952(a) and Sec.
958(a), and in accordance
with 21 CFR
1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: September 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement Administration.
[FR Doc. E7-18704 Filed 9-20-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
